This study will investigate the impact of high- and moderate-intensity exercise on the cardiometabolic and brain health of women with Polycystic Ovary syndrome (PCOS). The aim is to measure and compare normal, healthy women without PCOS, to those with the condition. All participants will undergo a blood test. The investigators will then assess the participants cardiovascular fitness by means of a maximal exercise test and measure body composition through height, weight, and hip-to-waist ratio. Participants will undergo an MRI, where the investigators will assess the participants brain structure and how the brain responds to a number of tests. The investigators will also conduct some tests that will assess the participants cognition, such as IQ, memory etc. The investigators will measure the blood vessels leading to the brain and the blood flow through them to measure how much blood the brain receives when rested, using ultrasound. The investigators will use a number of tests to look at brain function, measure the responses to these tests, and compare them between the normal, healthy women and those with PCOS. This will show if women with PCOS have a similar brain function when rested and when their brains are tested to those without the condition. The investigators will use exercise as an intervention, where the aim will be to investigate whether women with PCOS respond similarly to those without the condition to both high-intensity and moderate-intensity exercise. The tests of brain function will be repeated following the exercise, and see if both normal, healthy women and those with PCOS have a similar response to the brain function tests. All tests and measures will be compared between the PCOS group, and the healthy control group to establish any potential differences or similarities as a result of the condition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
34
Acute, low-volume HIIT 12x (1min:1min) Working intensity: \>85% heart rate reserve Resting intensity: Active rest
Continuous, MISS 50mins Working intensity: 50-60% heart rate reserve
Cardiff Metropolitan University
Cardiff, United Kingdom
Cerebrovascular Reactivity to Carbon Dioxide (CO2)
6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.
Time frame: Baseline
Cerebrovascular Reactivity to Carbon Dioxide (CO2)
6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.
Time frame: Less than 1 hour post-exercise
Neurovascular coupling (NVC)
NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.
Time frame: Baseline
Neurovascular coupling (NVC)
NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.
Time frame: Less than 1 hour post-exercise
Dynamic cerebral autoregulation (dCA)
dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.
Time frame: Baseline
Dynamic cerebral autoregulation (dCA)
dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.
Time frame: Less than 1 hour post-exercise
Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise
MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.
Time frame: During high-intensity exercise (24 minutes)
Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise
MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.
Time frame: During moderate-intensity exercise (50 minutes)
Cardiorespiratory fitness (CRF)
CRF will be assessed via peak oxygen uptake using a step protocol on a cycle ergometer. to achieve VO2peak.
Time frame: Baseline
Cerebral structure
MRI will be employed to assess grey and white matter structure.
Time frame: Baseline
Cerebral blood flow
Functional MRI will be employed to assess global and regional cerebral blood flow.
Time frame: Baseline
Cerebral metabolic rate of oxygen consumption
Functional MRI will be employed to assess cerebral metabolic rate of oxygen consumption.
Time frame: Baseline
Cerebrovascular reactivity
Functional MRI will be employed to assess cerebrovascular reactivity during a breath hold challenge.
Time frame: Baseline
Cognitive testing
A comprehensive cognitive battery will be employed to test across multiple cognitive sub-domains (IQ, working memory, episodic memory, attention and executive function).
Time frame: Baseline
Blood pressure during exercise
Finger plethysmography will be used to non-invasively monitor systolic and diastolic blood pressure throughout both acute bouts of exercise.
Time frame: During High-intensity interval exercise (HIIT) (24 minutes) and Moderate-intensity steady state (MISS) (50 minutes) exercise
Hormone profile
Hormonal profile will be measured through blood sampling, including androstenedione, sex hormone binding globulin and testosterone. From these values, free androgen index (FAI) will be calculated.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline
Metabolic profile
Metabolic profile will be measured through blood sampling, including fasting glucose and fasting insulin. From these values, the homeostatic model assessment of insulin resistance (HOMA-IR) will be calculated.
Time frame: Baseline
Lipid profile
Lipid profile will be measured through blood sampling, including total cholesterol, high-density lipoproteins, low-density lipoproteins and triglycerides.
Time frame: Baseline